Skip to main content

Nonprofit · EIN 13-6193105

CROHNS & COLITIS FOUNDATION INC

Tax-exempt · NEW YORK, NY 10017

Financials

$81.8M$86.5M2023$85.2M$83.5M2024
Revenue Expenses · by fiscal year end
Financials of CROHNS & COLITIS FOUNDATION INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990 (amended)$85,182,348$83,504,823$1,677,525$50,647,406$47,415,737$3,231,669
December 31, 2023990$81,765,248$86,537,979-$4,772,731$54,000,124$52,035,314$1,964,810
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$73,888,862
of which government grants
$551,064
Program service revenue
$9,112,274
Investment income
$1,327,009
Royalties
$492,767
Net gain from sales of assets
$1,144,805
Net income from fundraising events
-$310,454
Net income from gaming
$310,454
Other revenue
$854,203

Expenses

Grants and similar amounts paid
$23,680,607
Compensation of officers, directors and key employees
$3,677,782
Other salaries and wages
$25,592,246
Salaries, compensation and benefits (total)
$39,220,848
Professional fundraising fees
$334,625
Legal fees
$37,265
Accounting fees
$200,380
Occupancy
$1,597,179
Travel
$760,301
Depreciation
$1,185,865
Program services (functional)
$67,988,912
Management and general (functional)
$9,511,891
Fundraising (functional)
$6,004,020

Balance sheet and other

Total assets, start of year
$54,000,124
Total assets, end of year
$50,647,406
Total liabilities, end of year
$47,415,737
Net assets, end of year
$3,231,669
Land, buildings and equipment
$4,826,301
Publicly traded securities
$967,721
Net assets without donor restrictions
-$6,300,153
Net assets with donor restrictions
$9,531,822
Gross receipts
$105,303,732
Employees
372
Volunteers
6,005
Year formed
1967
State of legal domicile
NY

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
MICHAEL OSSOPRESIDENT/CEO(NON-VOTING)
Trustee or director, Officer
35$604,255$157,943
ALAN MOSSCHIEF SCIENTIFIC OFFICER
Key employee
35$450,466$13,858
ROHIT SURICHIEF TECHNOLOGY OFFICER
Key employee
35$304,578$78,567
SHARON LUNGRINCHIEF OP. OFF./CHIEF FIN.
Officer
35$267,379$70,733
MARISA MAYERCHIEF LEGAL OFFICER
Highest-paid employee
35$259,396$76,835
ALLISON COFFEYCHIEF DEVELOPMENT OFFICER
Key employee
35$273,205$22,804
CHRISTY DESANTISCHIEF MKTNG. & COMM. OFFCR.
Key employee
35$256,701$26,914
ANGELA DOBESVICE PRESIDENT, IBD PLEXUS
Highest-paid employee
35$259,396$17,475
LAURA WINGATECHIEF EDU. SUPP. & ADVOC. OFFICER
Key employee
35$219,544$43,880
LEANA PATELVP, PEOPLE & CULTURE
Highest-paid employee
35$202,086$26,800
SARAH WEAVERVP, CLINICAL QUALITY & INNOVATION
Highest-paid employee
35$206,702$16,415
JACK MATARASSOSVP, DIGITAL MARKETING
Highest-paid employee
35$202,684$15,941
CHRIS FIDYKEVP, BUSINESS DEVELOPMENT
Key employee
35$213,952$4,083
DANIEL STONETREASURER
Trustee or director, Officer
1$0$0
JODI YELLENSECRETARY (THRU 03/2024)
Trustee or director, Officer
1$0$0
33 more people on this return
NameTitleHours / weekCompensation
JEFFREY MITTLEMANSECRETARY (AS OF 03/2024)
Trustee or director, Officer
1$0
BRENT POLK MDCHAIRMAN (THRU 03/2024)
Trustee or director, Officer
1$0
AMBER BACKHAUSCHAIRMAN (AS OF 03/2024)
Trustee or director, Officer
1$0
RHONDA BOLDINGTRUSTEE
Trustee or director
1$0
NOEL BROWNTRUSTEE (AS OF 03/2024)
Trustee or director
1$0
JOHN CAPODILUNOTRUSTEE
Trustee or director
1$0
CHASE CARPENTERTRUSTEE
Trustee or director
1$0
ROCIO CASTRILLONTRUSTEE (AS OF 03/2024)
Trustee or director
1$0
DEBORAH CRAWFORDTRUSTEE
Trustee or director
1$0
TOLULOPE FALAIYE MDTRUSTEE
Trustee or director
1$0
BECKY FLAHERTYTRUSTEE (AS OF 03/2024)
Trustee or director
1$0
ALEX FUNDERBURGTRUSTEE (THRU 03/2024)
Trustee or director
1$0
CHERYL GUERINTRUSTEE
Trustee or director
1$0
KEVIN HARLENTRUSTEE
Trustee or director
1$0
PETER HIGGINS MD PHD MSCNSAC CHAIR ELECT
Trustee or director, Officer
1$0
KELLY ISSOKSON MSRDCNSCTRUSTEE
Trustee or director
1$0
SEAN KELLEYTRUSTEE (THRU 03/2024)
Trustee or director
1$0
SANDRA KIM MDTRUSTEE (AS OF 03/2024)
Trustee or director
1$0
MICHELE KISSOUS-HUNTTRUSTEE (THRU 03/2024)
Trustee or director
1$0
ANNETTE MARTINEZTRUSTEE
Trustee or director
1$0
AUDRA MILLERTRUSTEE
Trustee or director
1$0
JOE MONKTRUSTEE (THRU 03/2024)
Trustee or director
1$0
MARK MURRAY PHDTRUSTEE (THRU 03/2024)
Trustee or director
1$0
ARMIN RAHMANIANTRUSTEE
Trustee or director
1$0
MEGAN RIEHL PSYDTRUSTEE (AS OF 03/2024)
Trustee or director
1$0
JONATHAN ROSETRUSTEE (AS OF 07/2024)
Trustee or director
1$0
DAVID RUBIN MDTRUSTEE
Trustee or director
1$0
FRANK RUSSOMANOTRUSTEE (THRU 03/2024)
Trustee or director
1$0
LORI SIEGEL RABINOWITZTRUSTEE
Trustee or director
1$0
ANDREW STERNTRUSTEE (AS OF 03/2024)
Trustee or director
1$0
NICHOLAS UZLTRUSTEE (THRU 06/2024)
Trustee or director
1$0
TROY VOLLERTSENTRUSTEE
Trustee or director
1$0
DOUGLAS WOLF MDTRUSTEE (AS OF 03/2024)
Trustee or director
1$0
990 for the year ended December 31, 2023: 46 people
NameTitleHours / weekCompensationOther / benefits
MICHAEL OSSOPRESIDENT/CEO(NON-VOTING)
Trustee or director, Officer
35$770,337$87,698
ROHIT SURICHIEF TECHNOLOGY OFFICER
Key employee
35$312,346$63,683
MICHAEL ELKOWCHIEF FIELD OFFICER
Key employee
35$280,491$51,304
SHARON LUNGRINCHIEF OP. OFF./CHIEF FIN. OFF.
Officer
35$269,413$57,219
JOHN MICHAEL MIZEEVP, BUSINESS DEVELOPMENT
Key employee
35$266,918$55,322
CAREN HELLERCHIEF SCIENCE OFFICER
Key employee
35$294,246$18,253
ALLISON COFFEYCHIEF DEVELOPMENT OFFICER
Key employee
35$274,705$22,153
JUDY HOFFSTEINCHIEF MKTNG. & COMM. OFFCR.
Key employee
35$238,360$44,521
MARISA MAYERCHIEF LEGAL OFFICER
Highest-paid employee
35$225,111$57,620
LAURA WINGATEEVP, EDU., SUPPORT & ADVOCACY
Highest-paid employee
35$226,326$34,702
JAIME BLANDASENIOR VICE PRESIDENT, FINANCE
Highest-paid employee
35$219,590$26,924
ANGELA DOBESVICE PRESIDENT, IBD PLEXUS
Highest-paid employee
35$209,622$15,826
ANDRES HURTADO-LORENZOSENIOR VICE PRESIDENT, TR & IBDV
Highest-paid employee
35$202,615$16,191
ALESSANDRO DINELLOTREASURER (THRU 03/2023)
Trustee or director, Officer
1$0$0
ALEX FUNDERBURGTRUSTEE
Trustee or director
1$0$0
AMBER BACKHAUSTRUSTEE
Trustee or director
1$0$0
REP ANDER CRENSHAWTRUSTEE (THRU 03/2023)
Trustee or director
1$0$0
ANNETTE MARTINEZTRUSTEE
Trustee or director
1$0$0
ARMIN RAHMANIANTRUSTEE
Trustee or director
1$0$0
AUDRA MILLERTRUSTEE
Trustee or director
1$0$0
BRENT POLK MDCHAIRMAN
Trustee or director, Officer
1$0$0
CHASE CARPENTERTRUSTEE
Trustee or director
1$0$0
CHERYL GUERINTRUSTEE (AS OF 03/2023)
Trustee or director
1$0$0
DANIEL STONETREASURER (AS OF 03/2023)
Trustee or director, Officer
1$0$0
DAVID RUBIN MDNSAC CHAIR
Trustee or director, Officer
1$0$0
DEBORAH CRAWFORDTRUSTEE
Trustee or director
1$0$0
FRANK RUSSOMANOTRUSTEE
Trustee or director
1$0$0
JEFFREY MITTLEMANTRUSTEE
Trustee or director
1$0$0
JODI YELLENSECRETARY
Trustee or director, Officer
1$0$0
JOE MONKTRUSTEE
Trustee or director
1$0$0
JOEL ROSH MDTRUSTEE (THRU 03/2023)
Trustee or director
1$0$0
JOHN CAPODILUNOTRUSTEE (AS OF 03/2023)
Trustee or director
1$0$0
KELLY ISSOKSON MSRDCNSCTRUSTEE (AS OF 03/2023)
Trustee or director
1$0$0
KEVIN HARLENTRUSTEE (AS OF 03/2023)
Trustee or director
1$0$0
LORI SIEGEL RABINOWITZTRUSTEE
Trustee or director
1$0$0
MARK MURRAY PHDTRUSTEE
Trustee or director
1$0$0
MEENA BEWTRATRUSTEE (THRU 03/2023)
Trustee or director
1$0$0
MICHELE KISSOUS-HUNTTRUSTEE
Trustee or director
1$0$0
NICHOLAS UZLTRUSTEE (AS OF 03/2023)
Trustee or director
1$0$0
NOEL BROWNTRUSTEE (THRU 03/2023)
Trustee or director
1$0$0
PETER HIGGINS MD PHD MSCNSAC CHAIR ELECT
Trustee or director, Officer
1$0$0
RHONDA BOLDINGTRUSTEE
Trustee or director
1$0$0
SEAN KELLEYTRUSTEE
Trustee or director
1$0$0
TOLULOPE FALAIYE MDTRUSTEE
Trustee or director
1$0$0
TROY VOLLERTSENTRUSTEE
Trustee or director
1$0$0
SHELBY MODELLCO-FOUNDER/TRUSTEE
Trustee or director
1$0$0

Address and contacts

Address (IRS master file)
733 3RD AVE STE 510, NEW YORK, NY 10017-3218
In care of
% RONALD GOLDSMAN VP FINANCE
Principal officer (990 for 2024)
MICHAEL OSSO, 733 THIRD AVENUE, NEW YORK, NY 10017
Signed the 990
MICHAEL OSSO, PRESIDENT & CEO
Phone
(800) 932-2423
Return prepared by
GRANT THORNTON ADVISORS LLC

Mission

FOR OVER FIVE DECADES, THE CROHN'S & COLITIS FOUNDATION ("THE FOUNDATION") HAS BEEN DEDICATED TO ITS MISSION OF FINDING A CURE FOR CROHN'S DISEASE AND ULCERATIVE COLITIS AND IMPROVING THE QUALITY OF LIFE OF CHILDREN AND ADULTS AFFECTED BY THESE DISEASES. (SEE SCHED O)THE FOUNDATION HAS DEFINED ITSELF BY SPONSORING THE BEST AND BRIGHTEST RESEARCHERS RESULTING IN GROUNDBREAKING STUDIES AND RESEARCH INITIATIVES TO ADVANCE THE UNDERSTANDING AND TREATMENT OF INFLAMMATORY BOWEL DISEASES ("IBD").

990 for the year ended December 31, 2024

Program accomplishments

  • SINCE ITS INCEPTION, THE CROHN'S & COLITIS FOUNDATION HAS PROVIDED MORE THAN $500 MILLION FOR RESEARCH ON THE TREATMENT AND CURES OF IBD. THE FOUNDATION FUNDS A SET OF PRIORITY RESEARCH INITIATIVES: MULTI-INSTITUTIONAL, MULTI-DISCIPLINARY, COLLABORATIVE RESEARCH PROJECTS TARGETING AREAS OF SCIENCE WITH A HIGH PROBABILITY OF ADVANCING TREATMENT. THE FOUNDATION HAS DEFINED ITSELF BY SPONSORING THE BEST AND BRIGHTEST RESEARCHERS RESULTING IN GROUNDBREAKING STUDIES AND RESEARCH INITIATIVES TO ADVANCE THE UNDERSTANDING AND TREATMENT OF INFLAMMATORY BOWEL DISEASES ("IBD"). (CONTINUED IN SCHEDULE O)THE FOUNDATION'S RESEARCH PORTFOLIO IS A COMBINATION OF BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH. DESIGNED TO CUT YEARS OFF THE RESEARCH PROCESS, IBD PLEXUS, THE FOUNDATION'S INNOVATIVE RESEARCH PLATFORM, IS THE SINGLE LARGEST IBD DATABASE IN THE US AND THE MOST COMPREHENSIVE IBD DATABASE IN THE WORLD. IT CURRENTLY PROVIDES RESEARCHERS WITH DATA FROM OVER 30,000 PATIENTS, INCLUDING 250,000 BIOSAMPLES (BLOOD, STOOL, AND INTESTINAL TISSUE).THE FOUNDATION LEADS THE WAY IN NEW, CRITICALLY IMPORTANT AREAS OF IBD RESEARCH, AND ACCELERATING NOVEL THERAPIES AND INNOVATIVE PRODUCTS THAT ADDRESS UNMET PATIENT NEEDS. IN 2020, THE FOUNDATION LAUNCHED THE MOST EXTENSIVE IBD-FOCUSED PRECISION NUTRITION EFFORT, TO BETTER UNDERSTAND THE DIRECT IMPACT THAT FOOD MAY HAVE IN THE MANAGEMENT OF IBD AND ON PATIENT QUALITY OF LIFE. THE FOUNDATION ALSO LAUNCHED THE SURGICAL RESEARCH NETWORK, OUR FIRST-EVER COORDINATED-FUNDING EFFORT TO STUDY SURGICAL OUTCOMES IN IBD, WITH OVER 50 CENTERS PARTICIPATING.
    Expenses $34,993,675 · grants $23,680,607 · revenue $8,790,214
  • THE CROHN'S & COLITIS FOUNDATION PROVIDES INFORMATION AND EDUCATION FOR THE MILLIONS OF INDIVIDUALS WITH IBD AND THEIR LOVED ONES THROUGH A VARIETY OF CHANNELS AT THE NATIONAL AND LOCAL LEVEL INCLUDING IN-PERSON AND WEB-BASED EDUCATION, SUPPORT PROGRAMS INCLUDING PEDIATRIC AND ADULT FOCUS INITIATIVES, IBD HELP CENTER ANSWERING QUESTIONS AND PROVDING SUPPORT FOR THOSE WITH IBD, AND NUMEROUS PRINTED MATERIALS PROVIDINGACCURATE AND UP-TO-DATE INFORMATION. IN A RECENT IMPACT STUDY, OVER 85% OF PATIENTS CONNECTED WITH THE FOUNDATION STATED THAT THE FOUNDATION HAS HAD A POSITIVE IMPACT ON THEIR IBD JOURNEY. THESE PATIENTS ALSO REPORTED BETTER SYMPTOM CONTROL THAN NON-FOUNDATION CONNECTED PATIENTS. (CONTINUED IN SCHEDULE O)THE FOUNDATION ALSO OFFERS PROFESSIONAL EDUCATION THROUGH OUR TWO SCIENTIFIC JOURNALS, INFLAMMATORY BOWEL DISEASES AND CROHN'S & COLITIS 360, AS WELL AS THROUGH HEALTH PROFESSIONAL EDUCATION PROGRAMS BOTH IN-PERSON AND WEB-BASED. IN ADDITION THE FOUNDATION HOSTS THE ANNUAL CROHN'S & COLITIS CONGRESS CONFERENCE. IN THE PAST YEAR, THE FOUNDATION LAUNCHED A PUBLIC SERVICE AWARENESS CAMPAIGN TO INCREASE FAMILIARITY OF IBD WITH THE GENERAL PUBLIC AND REDUCE THE STIGMA FOR THOSE INDIVIDUALS WITH IBD.
    Expenses $32,995,237 · revenue $322,060

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Check at the IRS
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
13-6193105
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1966
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$47,669,031
Income (IRS master file)
$99,410,323

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$85,182,348$83,504,823$50,647,406XML
990December 2023$81,765,248$86,537,979$54,000,124XML
990December 2022$81,491,223$82,569,900$57,441,645IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 13-6193105).

Questions about CROHNS & COLITIS FOUNDATION INC

What is the EIN of CROHNS & COLITIS FOUNDATION INC?
The employer identification number (EIN) of CROHNS & COLITIS FOUNDATION INC is 13-6193105.
Is CROHNS & COLITIS FOUNDATION INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1966.
Are donations to CROHNS & COLITIS FOUNDATION INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does CROHNS & COLITIS FOUNDATION INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of CROHNS & COLITIS FOUNDATION INC due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did CROHNS & COLITIS FOUNDATION INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of CROHNS & COLITIS FOUNDATION INC?
The 990 for the year ended December 31, 2024 names MICHAEL OSSO.
Who are the officers and directors of CROHNS & COLITIS FOUNDATION INC?
The 990 for the year ended December 31, 2024 lists 48 people; 13 received compensation from the organization, the highest $604,255 (MICHAEL OSSO, PRESIDENT/CEO(NON-VOTING)).
How much revenue does CROHNS & COLITIS FOUNDATION INC have?
On its 990 for the year ended December 31, 2024 it reported revenue of $85,182,348, expenses of $83,504,823 and total assets of $50,647,406 at year end.

Other nonprofits in NEW YORK

All nonprofits in NEW YORK · New York · Voluntary health associations and medical disciplines